The mGluR2 positive allosteric modulator, AZD8529, and cue-induced relapse to alcohol seeking in rats

Neuropsychopharmacology

Volumn 41, Issue 12, 2016, Pages 2932-2940

  Augier, Eric ^a   Dulman, Russell S ^b   Rauffenbart, Caroline ^b   Augier, Gaëlle ^a   Cross, Alan J ^c   Heilig, Markus ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^c ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

7 METHYL 5 (3 PIPERAZIN 1 YLMETHYL[1,2,4]OXADIAZOL 5 YL) 2 (4 TRIFLUOROMETHOXYBENZYL) 2,3 DIHYDROISOINDOL 1 ONE; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; METABOTROPIC RECEPTOR 2; SACCHARIN; UNCLASSIFIED DRUG; ALCOHOL; AZD8529; INDOLE DERIVATIVE; METABOTROPIC RECEPTOR; OXADIAZOLE DERIVATIVE;

ADULT; ALCOHOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASSOCIATION; CONTROLLED STUDY; DRINKING BEHAVIOR; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG SELF ADMINISTRATION; GENE MUTATION; LOCOMOTION; MALE; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; RAT; RELAPSE; STOP CODON; ANIMAL; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; DRUG SEEKING BEHAVIOR; DRUG THERAPY; INSTRUMENTAL CONDITIONING; METABOLISM; RECURRENT DISEASE; REINFORCEMENT; WISTAR RAT;

ALCOHOL DRINKING; ANIMALS; CONDITIONING, OPERANT; CUES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG-SEEKING BEHAVIOR; ETHANOL; EXTINCTION, PSYCHOLOGICAL; INDOLES; MALE; OXADIAZOLES; RATS; RATS, WISTAR; RECEPTORS, METABOTROPIC GLUTAMATE; RECURRENCE; REINFORCEMENT (PSYCHOLOGY); SACCHARIN; SELF ADMINISTRATION;

EID: 84978743838     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2016.107     Document Type: Article

References (41)

1. Augier E, Dulman RS, Singley E, Heilig M. (2016). A method for evaluating the reinforcing properties of ethanol in rats without water deprivation, saccharin fading or extended access training. J Vis Exp (in press
2. Augier E, Flanigan M, Dulman RS, Pincus A, Schank JR, Rice KC., et al. (2014). Wistar rats acquire and maintain self-Administration of 20% ethanol without water deprivation, saccharin/sucrose fading, or extended access training. Psychopharmacology (Berl) 231: 4561-4568
3. Backstrom P, Hyytia P. (2005). Suppression of alcohol selfadministration and cue-induced reinstatement of alcohol seeking by the mGlu2/3 receptor agonist LY379268 and the mGlu8 receptor agonist (S)-3, 4-DCPG. Eur J Pharmacol 528: 110-118
4. Baptista MA, Martin-Fardon R, Weiss F. (2004). Preferential effects of the metabotropic glutamate 2/3 receptor agonist LY379268 on conditioned reinstatement vs primary reinforcement: comparison between cocaine and a potent conventional reinforcer. J Neurosci 24: 4723-4727
5. Bossert JM, Busch RF, Gray SM. (2005). The novel mGluR2/3 agonist LY379268 attenuates cue-induced reinstatement of heroin seeking. Neuroreport 16: 1013-1016
6. Bossert JM, Liu SY, Lu L, Shaham Y. (2004). A role of ventral tegmental area glutamate in contextual cue-induced relapse to heroin seeking. J Neurosci 24: 10726-10730
7. Caprioli D, Venniro M, Zeric T, Li X, Adhikary S, Madangopal R., et al. (2015). Effect of the novel positive allosteric modulator of metabotropic glutamate receptor 2 AZD8529 on incubation of methamphetamine craving after prolonged voluntary abstinence in a rat model. Biol Psychiatry 78: 463-473
8. Conn PJ, Lindsley CW, Jones CK. (2009). Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophrenia. Trends Pharmacol Sci 30: 25-31
9. Conn PJ, Pin JP. (1997). Pharmacology and functions of metabotropic glutamate receptors. Annu Rev Pharmacol Toxicol 37: 205-237
10. Cross AJ. (2013). AZD8529-An mGluR2 positive allosteric modulator for the treatment of schizophrenia. Neuropsychopharmacology 38: S25
11. Dahchour A, De Witte P. (2000). Taurine blocks the glutamate increase in the nucleus accumbens microdialysate of ethanoldependent rats. Pharmacol Biochem Behav 65: 345-350
12. Dahchour A, De Witte P. (2003). Excitatory and inhibitory amino acid changes during repeated episodes of ethanol withdrawal: an in vivo microdialysis study. Eur J Pharmacol 459: 171-178
13. Gass JT, Olive MF. (2008). Glutamatergic substrates of drug addiction and alcoholism. Biochem Pharmacol 75: 218-265
14. Goodwin FL, Campisi M, Babinska I, Amit Z. (2001). Effects of naltrexone on the intake of ethanol and flavored solutions in rats. Alcohol 25: 9-19
15. Heilig M, Egli M. (2006). Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms. Pharmacol Ther 111: 855-876
16. Hermann D, Weber-FahrW, Sartorius A, Hoerst M, Frischknecht U, Tunc-Skarka N., et al. (2012). Translational magnetic resonance spectroscopy reveals excessive central glutamate levels during alcohol withdrawal in humans and rats. Biol Psychiatry 71: 1015-1021
17. Hodos W. (1961). Progressive ratio as a measure of reward strength. Science 134: 943-944
18. Jin X, Semenova S, Yang L, Ardecky R, Sheffler DJ, Dahl R., et al. (2010). The mGluR2 positive allosteric modulator BINA decreases cocaine self-Administration and cue-induced cocaineseeking and counteracts cocaine-induced enhancement of brain reward function in rats. Neuropsychopharmacology 35: 2021-2036
19. Justinova Z, Panlilio LV, Secci ME, Redhi GH, Schindler CW, Cross AJ et al 2015). The novel metabotropic glutamate receptor 2 positive allosteric modulator, ZD8529, decreases nicotine selfadministration and relapse in squirrel monkeys. Biol Psychiatry 78: 452-462
20. Kalivas PW. (2009). The glutamate homeostasis hypothesis of addiction. Nat Rev Neurosci 10: 561-572
21. Kenny PJ, Markou A. (2004). The ups and downs of addiction: role of metabotropic glutamate receptors. Trends Pharmacol Sci 25: 265-272
22. Kufahl PR, Watterson LR, Nemirovsky NE, Hood LE, Villa A, Halstengard C., et al. (2013). Attenuation of methamphetamine seeking by the mGluR2/3 agonist LY379268 in rats with histories of restricted and escalated self-Administration. Neuropharmacology 66: 290-301
23. Li TK, Lumeng L, Doolittle DP. (1993). Selective breeding for alcohol preference and associated responses. Behav Genet 23: 163-170
24. Li TK, Lumeng L, McBride WJ, Waller MB, Murphy JM. (1986). Studies on an animal model of alcoholism. NIDA Res Monogr 66: 41-49
25. Liechti ME, Lhuillier L, Kaupmann K, Markou A. (2007). Metabotropic glutamate 2/3 receptors in the ventral tegmental area and the nucleus accumbens shell are involved in behaviors relating to nicotine dependence. J Neurosci 27: 9077-9085
26. Lu L, Uejima JL, Gray SM, Bossert JM, Shaham Y. (2007). Systemic and central amygdala injections of the mGluR(2/3) agonist LY379268 attenuate the expression of incubation of cocaine craving. Biol Psychiatry 61: 591-598
27. Marino MJ, Conn PJ. (2006). Glutamate-based therapeutic approaches: allosteric modulators of metabotropic glutamate receptors. Curr Opin Pharmacol 6: 98-102
28. McBride WJ, Li TK. (1998). Animal models of alcoholism: neurobiology of high alcohol-drinking behavior in rodents. Crit Rev Neurobiol 12: 339-369
29. Meinhardt MW, Hansson AC, Perreau-Lenz S, Bauder-Wenz C, Stahlin O, Heilig M., et al. (2013). Rescue of infralimbic mGluR2 deficit restores control over drug-seeking behavior in alcohol dependence. J Neurosci 33: 2794-2806
30. Meldrum BS. (2000). Glutamate as a neurotransmitter in the brain: review of physiology and pathology. J Nutr 130: 1007S-1015S.
31. Pin JP, Duvoisin R. (1995). The metabotropic glutamate receptors: structure and functions. Neuropharmacology 34: 1-26
32. Ritzen A, Mathiesen JM, Thomsen C. (2005). Molecular pharmacology and therapeutic prospects of metabotropic glutamate receptor allosteric modulators. Basic Clin Pharmacol Toxicol 97: 202-213
33. Rodd ZA, McKinzie DL, Bell RL, McQueen VK, Murphy JM, Schoepp DD., et al. (2006). The metabotropic glutamate 2/3 receptor agonist LY404039 reduces alcohol-seeking but not alcohol self-Administration in alcohol-preferring (P) rats. Behav Brain Res 171: 207-215
34. Rossetti ZL, Carboni S. (1995). Ethanol withdrawal is associated with increased extracellular glutamate in the rat striatum. Eur J Pharmacol 283: 177-183
35. Schaffhauser H, Rowe BA, Morales S, Chavez-Noriega LE, Yin R, Jachec C., et al. (2003). Pharmacological characterization and identification of amino acids involved in the positive modulation of metabotropic glutamate receptor subtype 2. Mol Pharmacol 64: 798-810
36. Schoepp DD, Jane DE, Monn JA. (1999). Pharmacological agents acting at subtypes of metabotropic glutamate receptors. Neuropharmacology 38: 1431-1476
37. Sidhpura N, Weiss F, Martin-Fardon R. (2010). Effects of the mGlu2/3 agonist LY379268 and the mGlu5 antagonist MTEP on ethanol seeking and reinforcement are differentially altered in rats with a history of ethanol dependence. Biol Psychiatry 67: 804-811
38. Spooren W, Ballard T, Gasparini F, Amalric M, Mutel V, Schreiber R. (2003). Insight into the function of Group I and Group II metabotropic glutamate (mGlu) receptors: behavioural characterization and implications for the treatment of CNS disorders. Behav Pharmacol 14: 257-277
39. Umhau JC, Momenan R, Schwandt ML, Singley E, Lifshitz M, Doty L et al 2010). ffect of acamprosate on magnetic resonance spectroscopy measures of central glutamate in detoxified alcoholdependent individuals: a randomized controlled experimental medicine study. Arch Gen Psychiatry 67: 1069-1077
40. Zhao Y, Dayas CV, Aujla H, Baptista MA, Martin-Fardon R, Weiss F. (2006). Activation of group II metabotropic glutamate receptors attenuates both stress and cue-induced ethanol-seeking and modulates c-fos expression in the hippocampus and amygdala. J Neurosci 26: 9967-9974
41. Zhou Z, Karlsson C, Liang T, Xiong W, Kimura M, Tapocik JD., et al. (2013). Loss of metabotropic glutamate receptor 2 escalates alcohol consumption. Proc Natl Acad Sci USA 110: 16963-16968